|
WO2020172757A1
|
|
Lawsonia intracellularis compositions and methods of using the same
|
|
WO2020102892A1
|
|
3'-unsaturated abscisic acid derivatives as aba antagonists
|
|
CA3057017A1
|
|
Method for producing seed with depleted glycosides and heavy metals
|
|
WO2020056524A1
|
|
Mucoadhesive lipidic delivery system
|
|
WO2020037397A1
|
|
Implant for bone fracture stabilization
|
|
WO2020024059A1
|
|
Oligosaccharides as oligomolecular tags
|
|
WO2019227226A1
|
|
Phytochemical-antibiotic combination for the treatment of a bacterial infection
|
|
WO2019210397A1
|
|
Phytochemical antibiotic conjugates as inhibitors of lactobacillales bacteria
|
|
WO2019191847A1
|
|
Methods and uses of modulators of anaphase promoting complex (apc) activity for treating cancer
|
|
US2019274950A1
|
|
Modified release formulations of mycophenolate mofetil
|
|
WO2019104446A1
|
|
Protein-free semen cryopreservation
|
|
CA3079470A1
|
|
Dehydration using biosorbents in modified pressure swing adsorption
|
|
WO2019075574A1
|
|
Conduritol aziridine derivatives and uses thereof
|
|
US2020264084A1
|
|
Methods for Detecting Pipeline Weakening
|
|
US2020207868A1
|
|
Her3 binding agents and uses thereof
|
|
US2020164066A1
|
|
Methods and Compositions for Inducing Protective Immunity
|
|
WO2018184107A1
|
|
Peptides and methods and uses thereof for modulating anaphase promoting complex (apc) activity
|
|
CA3054381A1
|
|
Egfr-binding agents and uses thereof
|
|
WO2018068152A1
|
|
Surgical retractor device to protect underlying tissue
|
|
US2020062782A1
|
|
Bifunctional alpha-synuclein binding agents and uses thereof
|
